Conference Speakers & Topic(s)
Dr. Edgar J.G. Peters
Dr. Edgar J.G. Peters started medical school in Amsterdam, The Netherlands in 1993. He has worked in 1997 and 1998 as a researcher at the University of Texas Health Science Center in San Antonio, Texas, USA. He graduated medical school of VU University Medical Center in Amsterdam in 2000 cum laude. In 2002, he finished a PhD thesis on diabetic foot complications. He is dually registered in both Infectious Diseases and Acute Medicine. He currently works as Internist, Infectious Diseases and Acute Medicine Specialist at Amsterdam University Medical Centers, location VUmc, where he is the director of the Infectious Diseases Fellowship Program. His main research interest is infections of the musculoskeletal system, especially diabetic foot infections and bone infection. Recent research projects were to the microbiome of diabetic foot bone infection (osteomyelitis), monitoring treatment of osteomyelitis with biomarkers, cold atmospheric plasma treatment of diabetic foot ulcers, and diagnostic strategies for diabetic foot osteomyelitis. He has combined diabetic foot research with research to other musculoskeletal infections, e.g., prosthetic joint prosthesis associated infection. He has also been involved in writing guidelines for treatment of diabetic foot complications for the Infectious Diseases Society of America, the Wound Healing Society, the European Wound Management Association, the International Working Group on the Diabetic Foot and the Dutch Internist Society (NIV). He also chairs the Dutch guideline committee for prosthetic joint associated infections. He is the Scientific Secretary of the International Symposium on the Diabetic Foot. Edgar Peters has authored over 100 journal articles and books chapters.
Practical approach to antibiotic choice for infected diabetic foot ulcers
In the presentation, we will cover the practical advice for empirical antibiotic treatment of infected diabetic foot ulcers, based on the recent update of the guidelines of the International Working Group on the Diabetic Foot. We will discuss the following: infection is a clinical diagnosis. If you want to prescribe adequate empirical antibiotic treatment for diabetic foot infection, you have to know the local resistance profile of pathogens. In case of mild infection, target Staphylococcus aureus and streptococci. In case of moderate to severe infections, include coverage for gram negative organisms.